Holen Sie sich die Stockscreener-App
34.15
0.03%
-0.010
Handel nachbörslich:
34.14
-0.010
-0.03%
Schlusskurs vom Vortag:
$34.16
Offen:
$34.105
24-Stunden-Volumen:
625.48K
Relative Volume:
3.75
Marktkapitalisierung:
$313.94M
Einnahmen:
$103.14M
Nettoeinkommen (Verlust:
$-5.82M
KGV:
-7.8459
EPS:
-4.3526
Netto-Cashflow:
$2.14M
1W Leistung:
+0.15%
1M Leistung:
+45.63%
6M Leistung:
+80.59%
1J Leistung:
+12.34%
1-Tages-Spanne:
$34.09
$34.23
1-Wochen-Bereich:
$33.68
$34.39
52-Wochen-Spanne:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Firmenname
Sanara Medtech Inc
Sektor
Telefon
817-529-2300
Adresse
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
34.15 | 315.60M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Lake Street | Buy |
| 2025-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-20 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - marketbeat.com
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - marketbeat.com
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech (SMTI) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - marketbeat.com
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - marketbeat.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - marketscreener.com
How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy - marketbeat.com
SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire
MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0
MiMedx Group: Sanara Deal Comes At A Poor Time - Seeking Alpha
Sanara MedTech agrees to be acquired by MiMedx - TipRanks
MIMEDX to acquire Sanara MedTech for $350 million By Investing.com - Investing.com Nigeria
Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger - TradingView
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech - TradingView
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx Group, Inc. entered into a definitive merger agreement to acquire Sanara MedTech Inc. for approximately $340 million. - marketscreener.com
Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI - TradingView
Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):